Overall, our findings strongly support further investigation for the clinical translation of B7-H3- and CSPG4-targeted CAR T cell-based immunotherapies for the treatment of anaplastic thyroid cancer. Here, CD276 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.